The activity of raltitrexed (Tomudex(R)) in malignant pleural mesothelioma - an EORTC phase II study (08992)

By Baas P.   Ardizzoni A.   Grossi F.   Nackaerts K.   Numico G.   Van Marck E.   van de Vijver M.   Monetti F.   Smid-Geirnaerdt M.J.A.   van Zandwijk N.   Debruyne C.   Legrand C.   Giaccone G.   on behalf of the EORTC Lung Cancer Group  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 353-357

Elsevier

Access to resources Recommend Favorite

Etoposide in Malignant Pleural Mesothelioma: Two Phase II Trials of the EORTC Lung Cancer Cooperative Group

By Sahmoud T.   Postmus P.E.   van Pottelsberghe C.   Mattson K.   Tammilehto L.   Splinter T.A.W.   Planting A.S.T.   Sutedja T.   van Pawel J.   van Zandwijk N.   Baas P.   Roozendaal K.J.   Schrijver M.   Kirkpatrick A.   Van Glabbeke M.   Ardizzoni A.   Giaccone G.  

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2211-2215

Elsevier

Access to resources Recommend Favorite

Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

By Woll P.J.   Judson I.   Lee S.M.   Rodenhuis S.   Nielsen O.S.   Buesa J.M.   Lorigan P.C.   Leyvraz S.   Hermans C.   van Glabbeke M.   Verweij J.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 410-412

Elsevier

Access to resources Recommend Favorite

Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases - a phase II study of the EORTC Lung Cancer Group (08965)

By Dziadziuszko R.   Ardizzoni A.   Postmus P.E.   Smit E.F.   Price A.   Debruyne C.   Legrand C.   Giaccone G.   on behalf of the EORTC Lung Cancer Group  

European Journal of Cancer, Vol. 39, Iss. 9, 2003-06 ,pp. : 1271-1276

Elsevier

Access to resources Recommend Favorite

Chemotherapy for Malignant Pleural Mesothelioma

By Garland Linda  

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite